awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36055167-48D0697C-2865-4839-87AC-0090752845A4
Q36055167-48D0697C-2865-4839-87AC-0090752845A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36055167-48D0697C-2865-4839-87AC-0090752845A4
The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease
P2860
Q36055167-48D0697C-2865-4839-87AC-0090752845A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36055167-48D0697C-2865-4839-87AC-0090752845A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ceaf00dce8827f08b219fb2b271254a1f1679509
P2860
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I